Literature DB >> 19289776

Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands.

Andrew H Kalajian, Jennifer H Perryman, Jeffrey P Callen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19289776     DOI： 10.1001/archdermatol.2008.620

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

Review 1.  The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors:  Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

2.  An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.

Authors:  Magalys Vitiello; Adriana Abuchar; Néstor Santana; Luis Dehesa; Francisco A Kerdel
Journal:  J Clin Aesthet Dermatol       Date:  2012-07

3.  Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis.

Authors:  María Pilar Cruz-Domínguez; Grettel García-Collinot; Miguel A Saavedra; Gabriela Medina; Rosa Angélica Carranza-Muleiro; Olga Lidia Vera-Lastra; Luis J Jara
Journal:  Clin Rheumatol       Date:  2016-10-07       Impact factor: 2.980

Review 4.  Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome.

Authors:  Tadashi Nakamura; Kei Hirakawa; Hirokazu Takaoka; Ken-Ichi Iyama
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

5.  Treatment of calcinosis associated with adult and juvenile dermatomyositis using topical sodium thiosulfate via fractionated CO2 laser treatment.

Authors:  Misty G Eleryan; Olabola Awosika; Sophia Akhiyat; Azam Qureshi; Monica Rengifo-Pardo; Rodolfo Curiel; Lisa G Rider; Alison Ehrlich
Journal:  Clin Exp Rheumatol       Date:  2019-11-18       Impact factor: 4.473

6.  Dystrophic calcinosis in a patient with overlap syndrome (scleroderma and rheumatoid arthritis) treated by leflunomide: A case report.

Authors:  Sang Yeob Lee; Sung Won Lee; Won Tae Chung
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.